We are surprised to see several serious errors have crept into systematic review and meta-analysis on selenium and preeclampsia (PE) by Xu et al., (October 2015) [1], detailed below.
Sir,
We are surprised to see several serious errors have crept into systematic review and meta-analysis on selenium and preeclampsia (PE) by Xu et al., (October 2015) [1] , detailed below.
First, we believe they have misinterpreted our data published in Hypertension [2] . The authors state that 'Se in the umbilical cord was significantly lower in the PE group than in the control while not in serum in two studies [25, 26] ' where reference 26 is our manuscript. But our data show that the umbilical venous serum selenium concentrations were lower in the PE group: 'Selenium concentrations were significantly reduced in umbilical venous samples in preeclampsia by comparison with samples from babies of normotensive mothers (P < 0.0001)'. Secondly, the numbers quoted in the manuscript Table 1 and Figure 2 are incorrect and should be (mean ± SD) normotensive 42.1 ± 11.8; PE 29.0 ± 9.9 μg/L; these have been written the wrong way around and thus significantly affects the results of the authors analyses, particularly in relation to the data presented in Figure 2 .
In addition to the above, in both our manuscripts [2; 3], we have clearly stated the PE criteria, which are detailed in the methods. Finally, the mean age (year) for the women used in our study is published in Table 1 of the manuscript [3] .
We would be grateful of some acknowledgement to the original manuscript that the error will affect the systematic review and meta-analysis results. On finding these errors, we are concerned that similar errors may have occurred to other manuscripts referenced in this systematic review/metaanalysis.
